Follow-The-Filings

Security

Abeona Therapeutics Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 new max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $22M
qoq N 1 A 3 R 4

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,757,143 $15M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 589,847 $3M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 425,426 $2M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 216,305 $969 hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 161,082 $722 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 102,645 $460 hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 101,065 $453 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 55,837 $250 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.5M $5.82M
Gross profit * $4.29M
Gross margin * 73.7%
Net income -$54.19M -$63.73M $71.18M
Net margin * -1548.2% 1223.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $55.74M $100.85M $204.91M
Total non-current assets * $8.26M $8.08M $14.66M
Total assets $64M $108.93M $219.57M
Total current liabilities $13.42M $16.59M $29.57M
Total non-current liabilities * $35.75M $48.31M $30.78M
Total equity $14.83M $44.03M $159.22M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$37.01M -$56.02M -$76.33M
Cash from investing $208,000 -$39.24M $105.03M
Cash from financing $37.06M $104.14M $26.04M
Net change in cash $256,000 $8.88M $54.74M

ownership over time

filing count by report period · click a bar for that quarter’s holders